Cargando…

Novel ALK-specific mRNA in situ hybridization assay for non-small-cell lung carcinoma

BACKGROUND: A recent technical advance in mRNA in situ hybridization (mRNA-ISH) assays provides simultaneous signal amplification and background suppression with a unique probe design that enables single-molecule visualization. We assessed the utility of the mRNA-ISH assay as a diagnostic tool for d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hirai, Noriko, Sasaki, Takaaki, Okumura, Shunsuke, Sado, Masatoshi, Akiyama, Naoko, Kitada, Masahiro, Takei, Hidehiro, Ohsaki, Yoshinobu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225155/ https://www.ncbi.nlm.nih.gov/pubmed/32420065 http://dx.doi.org/10.21037/tlcr.2020.03.04

Ejemplares similares

Monomerization of ALK Fusion Proteins as a Therapeutic Strategy in ALK-Rearranged Non-small Cell Lung Cancers
por: Hirai, Noriko, et al.
Publicado: (2020)

Observation of Zn-photoprotoporphyrin red Autofluorescence in human bronchial cancer using color-fluorescence endoscopy
por: Ohsaki, Yoshinobu, et al.
Publicado: (2017)

The value and practical utility of intraoperative touch imprint cytology of sentinel lymph node(s) in patients with breast cancer: A retrospective cytology-histology correlation study
por: Uno, Yuji, et al.
Publicado: (2020)

Interstitial lung disease associated with human papillomavirus vaccination
por: Yamamoto, Yasushi, et al.
Publicado: (2015)

Acute eosinophilic pneumonia following inhalation of turpentine oil: A case report
por: Umekage, Yasuhiro, et al.
Publicado: (2020)

Cyclin-dependent kinase 4 upregulation mediates acquired resistance of dabrafenib plus trametinib in BRAF V600E-mutated lung cancer
por: Hirai, Noriko, et al.
Publicado: (2021)

Histamine H(1) antagonist levocetirizine as a potential cause of lung injury
por: Endo, Satoshi, et al.
Publicado: (2015)

Highly sensitive detection of ALK resistance mutations in plasma using droplet digital PCR
por: Yoshida, Ryohei, et al.
Publicado: (2018)

Leiomyoma of the Trachea: a case report
por: Kitada, Masahiro, et al.
Publicado: (2015)

Non-islet cell tumor hypoglycemia caused by intrathoracic solitary fibrous tumor: a case report
por: Kitada, Masahiro, et al.
Publicado: (2016)

Photodynamic diagnosis of pleural malignant lesions with a combination of 5-aminolevulinic acid and intrinsic fluorescence observation systems
por: Kitada, Masahiro, et al.
Publicado: (2015)

Successful alectinib treatment after crizotinib‐induced interstitial lung disease
por: Fujiuchi, Satoru, et al.
Publicado: (2016)

IgG4-related lung disease showing high standardized uptake values on FDG-PET: report of two cases
por: Kitada, Masahiro, et al.
Publicado: (2013)

Evaluation of a Quantitative Serological Assay for Diagnosing Chronic Pulmonary Aspergillosis
por: Fujiuchi, Satoru, et al.
Publicado: (2016)

Major pathologic response to alectinib in ALK-rearranged adenocarcinoma of the lung
por: Imanishi, Naoko, et al.
Publicado: (2018)

Detection of resistance mutations in patients with anaplastic lymphoma kinase-rearranged lung cancer through liquid biopsy
por: Sasaki, Takaaki, et al.
Publicado: (2023)

Identification of circulating tumor cells with EML4-ALK translocation using fluorescence in situ hybridization in advanced ALK-positive patients with lung cancer
por: Kim, Young Hun, et al.
Publicado: (2018)

Identification of circulating tumor cells with EML4-ALK translocation using fluorescence in situ hybridization in advanced ALK-positive patients with lung cancer
por: Kim, Young Hun, et al.
Publicado: (2019)

Anaplastic lymphoma kinase (ALK) inhibitor response in neuroblastoma is highly correlated with ALK mutation status, ALK mRNA and protein levels
por: Duijkers, Floor A. M., et al.
Publicado: (2011)

ALK Gene Rearrangements in Lung Adenocarcinomas: Concordance of Immunohistochemistry, Fluorescence In Situ Hybridization, RNA In Situ Hybridization, and RNA Next-Generation Sequencing Testing
por: Canterbury, Carleigh R., et al.
Publicado: (2021)

Analysis of MET mRNA Expression in Gastric Cancers Using RNA In Situ Hybridization Assay: Its Clinical Implication and Comparison with Immunohistochemistry and Silver In Situ Hybridization
por: Choi, Jiwoon, et al.
Publicado: (2014)

ALK (D5F3) CDx: an immunohistochemistry assay to identify ALK-positive NSCLC patients
por: Uruga, Hironori, et al.
Publicado: (2018)

The analysis of ALK gene rearrangement by fluorescence in situ hybridization in non-small cell lung cancer patients
por: Wojas-Krawczyk, Kamila, et al.
Publicado: (2013)

Detection of an ALK Fusion in Colorectal Carcinoma by Hybrid Capture‐Based Assay of Circulating Tumor DNA
por: Lai, Andrea Z., et al.
Publicado: (2017)

Fluorescence In Situ Hybridization and Immunohistochemistry as Diagnostic Methods for ALK Positive Non-Small Cell Lung Cancer Patients
por: Martinez, Pablo, et al.
Publicado: (2013)

A stealth antigen SPESP1, which is epigenetically silenced in tumors, is a suitable target for cancer immunotherapy
por: Kosaka, Akemi, et al.
Publicado: (2021)

Novel In Situ Hybridization Assay for Chromogenic Single-Molecule Detection of Human Papillomavirus E6/E7 mRNA
por: Rao, Xuelian, et al.
Publicado: (2023)

Concurrent Granulomatous Mastitis and Ductal Carcinoma In Situ
por: Yoshida, Nana, et al.
Publicado: (2023)

Novel mRNA-containing cytoplasmic granules in ALK-transformed cells
por: Fawal, Mohamad, et al.
Publicado: (2011)

Detection of ALK Gene Rearrangements in Non-Small Cell Lung Cancer by Immunocytochemistry and Fluorescence in Situ Hybridization on Cytologic Samples
por: Rachagiri, Suneel, et al.
Publicado: (2022)

Ultrahigh strength and shear-assisted separation of sliding nanocontacts studied in situ
por: Sato, Takaaki, et al.
Publicado: (2022)

Estrogen Receptor-α Quantification in Breast Cancer: Concordance Between Immunohistochemical Assays and mRNA-In Situ Hybridization for ESR1 Gene
por: Thomsen, Christian, et al.
Publicado: (2020)

Proximity Ligation Assays for In Situ Detection of Innate Immune Activation: Focus on In Vitro-Transcribed mRNA
por: Blanchard, Emmeline L., et al.
Publicado: (2018)

YAP1 mediates survival of ALK-rearranged lung cancer cells treated with alectinib via pro-apoptotic protein regulation
por: Tsuji, Takahiro, et al.
Publicado: (2020)

Novel method for rapid fluorescence in-situ hybridization of ALK rearrangement using non-contact alternating current electric field mixing
por: Fujishima, Satoshi, et al.
Publicado: (2017)

Fluorescence in Situ Hybridization (FISH) for Detecting Anaplastic Lymphoma Kinase (ALK) Rearrangement in Lung Cancer: Clinically Relevant Technical Aspects
por: Tang, Zhenya, et al.
Publicado: (2019)

Status quo of ALK testing in lung cancer: results of an EQA scheme based on in-situ hybridization, immunohistochemistry, and RNA/DNA sequencing
por: Jurmeister, Philipp, et al.
Publicado: (2021)

Silver-Enhanced In Situ Hybridization as an Alternative to Fluorescence In Situ Hybridization for Assaying HER2 Amplification in Clinical Breast Cancer
por: Park, Kyeongmee, et al.
Publicado: (2011)

Nivolumab Therapy for Synchronous ALK-Positive Lung Cancer and Gastric Cancer
por: Yamasaki, Masahiro, et al.
Publicado: (2017)

Anti-ALK Antibodies in Patients with ALK-Positive Malignancies Not Expressing NPM-ALK
por: Damm-Welk, Christine, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_i6k23lrkoo0qgg15jods05pa1j